BBVA USA’s Dentsply Sirona XRAY Stock Holding History
Bought
Maintained
Sold
Other funds holding XRAY
ACM
GIM
CIP
BBVA USA's XRAY Position: Q3 2021 in Review
BBVA USA reduced its Dentsply Sirona (XRAY) stake by 4.5% in Q3 2021, selling an estimated $58.6K and leaving 20,015 shares worth $1.16M. The position accounts for 0.07% of the portfolio, ranked #244.
BBVA USA first reported a position in XRAY in Q2 2021 and has held it in 2 quarters since. The position peaked at $1.33M in Q2 2021. 553 funds tracked by Wall St. Rank hold XRAY as of Q3 2021.
- BBVA USA held 20,015 shares of Dentsply Sirona worth $1.16M as of Q3 2021.
- BBVA USA sold 951 Dentsply Sirona shares in Q3 2021, an estimated $58.6K.
- Dentsply Sirona made up 0.07% of BBVA USA's portfolio in Q3 2021, its #244 holding.
- BBVA USA first reported a position in Dentsply Sirona in Q2 2021 and has held it in 2 quarters since.
- BBVA USA's Dentsply Sirona position peaked at $1.33M in Q2 2021.
- 553 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2021.
Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.